- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03005457
Pilot Study to Assess the Feasibility and Initial Efficacy of Therapist-as-consultant, Game-based CI Therapy
25. december 2016 opdateret af: Lynne Gauthier , PhD, Ohio State University
A Low-cost Virtual Reality Gaming Platform for Neurorehabilitation of Hemiparesis
Pilot study to assess the feasibility and initial efficacy of therapist-as-consultant, game-based CI therapy.
Pre/post study design.
Participant received a target of 30 hours game-based motor intervention, 100 hours constraint of the less affected upper extremity, and 5 hours therapist consultation (including completion of a behavioral contract at the first study visit).
Duration of intervention was 10 consecutive weekdays, with pre-treatment and post-treatment testing performed within 1 week prior to and 1 week post-intervention by an independent tester.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
32
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Ohio
-
Columbus, Ohio, Forenede Stater, 43210
- The Ohio State University, 2154 Dodd Hall
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Provide signed and dated informed consent form
- Willing to comply with all study procedures and be available for the duration of the study
- Male or female aged > 17
- Preserved ability to comprehend English and participate in basic elements of the therapy
- Community-dwelling
- Experienced mild to moderate hemiparesis at least six months prior
- Can independently operate the gaming system (those with severe cognitive impairments can usually achieve this)
- Corrected vision of at least 20/70 as assessed by their ability to identify game objects on the monitor from 5 feet away
Exclusion Criteria:
- concurrent participation in other experimental upper extremity trials
- concurrent participation in other outpatient rehabilitation for their upper extremity
- Botox within the last 3 months (confound)
- near-normal motor function (9-hole Peg Test score above the 10th percentile of a normative sample)
- minimal nonuse (Motor Activity Log at baseline >2.5, Accelerometry > 60%)
- major medical issues that would interfere with study treatments or make intensive rehabilitation difficult to tolerate
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Ikke-randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Slag
|
An in-home therapist-as-consultant model of CI therapy in which motor practice with shaping and the Motor Activity Log with problem solving were delivered via a custom avatar-based video game called Recovery Rapids
|
|
Eksperimentel: Hemiparesis other
|
An in-home therapist-as-consultant model of CI therapy in which motor practice with shaping and the Motor Activity Log with problem solving were delivered via a custom avatar-based video game called Recovery Rapids
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Motor Activity Log
Tidsramme: Week 0 and Week 3
|
Self-report measure of arm use for daily activities
|
Week 0 and Week 3
|
|
Change in Wolf Motor Function Test
Tidsramme: Week 0 and Week 3
|
Objective measure of motor function in a laboratory setting
|
Week 0 and Week 3
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Kinematic Data
Tidsramme: Week 0 and Week 3
|
Kinematic data recorded during game play
|
Week 0 and Week 3
|
|
Brief Kinesthesia test
Tidsramme: Week 0 and Week 3
|
Clinical Assessment of sensation
|
Week 0 and Week 3
|
|
Patient Health Questionnaire
Tidsramme: Week 0 and Week 3
|
Measures Depression
|
Week 0 and Week 3
|
|
Strok Specific Quality of Life Scale
Tidsramme: Week 0 and Week 3
|
Quality of life measurement
|
Week 0 and Week 3
|
|
Weschler Adult Intelligence Scale Symbol Seach
Tidsramme: Week 0 and Week 3
|
Cognitive processing speed assessment
|
Week 0 and Week 3
|
|
Montreal Cognitive Assessment
Tidsramme: Week 0 and Week 3
|
Baseline cognitive screen
|
Week 0 and Week 3
|
|
Survey
Tidsramme: Week 0 and Week 3
|
Survey on satisfaction with the intervention
|
Week 0 and Week 3
|
|
Mitt Compliance
Tidsramme: Week 0 and Week 3
|
Hours of use
|
Week 0 and Week 3
|
|
Total game-play time
Tidsramme: Week 0 and Week 3
|
Week 0 and Week 3
|
|
|
Gestures
Tidsramme: Week 0 and Week 3
|
Number of gestures of each type registered in game
|
Week 0 and Week 3
|
|
Bilateral activity monitors
Tidsramme: Week 0 and Week 3
|
Objective measure of arm use
|
Week 0 and Week 3
|
|
Action Research Arm Test (ARAT)
Tidsramme: Week 0 and Week 3
|
Asses Changes in Limb Function
|
Week 0 and Week 3
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. juli 2012
Primær færdiggørelse (Faktiske)
1. december 2014
Studieafslutning (Faktiske)
1. december 2014
Datoer for studieregistrering
Først indsendt
21. december 2016
Først indsendt, der opfyldte QC-kriterier
25. december 2016
Først opslået (Skøn)
29. december 2016
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
29. december 2016
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
25. december 2016
Sidst verificeret
1. december 2016
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 60047824
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
JA
IPD-planbeskrivelse
Will be shared upon publication acceptance.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Hemiparesis Therapy with VR
-
Texas Scottish Rite Hospital for ChildrenTexas Woman's UniversityAfsluttet
-
University of Michigan Rogel Cancer CenterNRG OncologyAfsluttetKræftrelateret kognitiv svækkelse | BrystkræftoverlevelseForenede Stater
-
New Jersey Institute of TechnologyKessler Foundation; Rutgers University; Northeastern UniversityAfsluttetSlagtilfælde, AkutForenede Stater
-
Hospices Civils de LyonAfsluttetPatienter med anterior åben bidfejl og som har haft gavn af en kæbekirurgisk operation | Spædbarnssvælgning og tungefejlstilling, der nødvendiggør tungegenoptræningFrankrig
-
University Hospital, Clermont-FerrandFondation de l'Avenir, FranceUkendtAfhængighed | Kokain-relaterede lidelserFrankrig
-
University Hospital, Clermont-FerrandNational Cancer Institute, FranceAfsluttetOphør med tobaksbrugFrankrig